We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$13.5B
AUM Growth
-$537M
Cap. Flow
-$203M
Cap. Flow %
-1.51%
Top 10 Hldgs %
19.68%
Holding
385
New
13
Increased
113
Reduced
185
Closed
7

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$46.3M
2
QCOM icon
Qualcomm
QCOM
+$36.9M
3
ATKR icon
Atkore
ATKR
+$27.5M
4
WTRG icon
Essential Utilities
WTRG
+$26.1M
5
HALO icon
Halozyme
HALO
+$19.4M

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$43.2M
2
CPE
Callon Petroleum Company
CPE
+$35.4M
3
UMBF icon
UMB Financial
UMBF
+$31M
4
SLB icon
SLB Ltd
SLB
+$30.8M
5
JPM icon
JPMorgan Chase
JPM
+$27.7M

Sector Composition

Rank Sector Weight
1 Technology 24.52%
2 Financials 14.32%
3 Healthcare 14.05%
4 Industrials 13.81%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
351
Dell
DELL
$346B
$279K ﹤0.01%
2,026
CDW icon
352
CDW
CDW
$19.2B
$271K ﹤0.01%
1,211
SHEL icon
353
Shell
SHEL
$283B
$271K ﹤0.01%
3,748
AIG icon
354
American International
AIG
$39.7B
$260K ﹤0.01%
3,500
CTAS icon
355
Cintas
CTAS
$79.6B
$256K ﹤0.01%
1,464
SCHF icon
356
Schwab International Equity ETF
SCHF
$68.4B
$255K ﹤0.01%
13,272
BEN icon
357
Franklin Templeton
BEN
$16.9B
$246K ﹤0.01%
11,000
NICE icon
358
Nice
NICE
$6.09B
$237K ﹤0.01%
1,380
MS icon
359
Morgan Stanley
MS
$324B
$235K ﹤0.01%
2,423
ICE icon
360
Intercontinental Exchange
ICE
$88.1B
$234K ﹤0.01%
1,712
CI icon
361
Cigna
CI
$76.3B
$234K ﹤0.01%
707
INGR icon
362
Ingredion
INGR
$6.25B
$232K ﹤0.01%
2,027
USMV icon
363
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$232K ﹤0.01%
2,767
GEV icon
364
GE Vernova
GEV
$235B
$230K ﹤0.01%
+1,339
New +$212K
NVS icon
365
Novartis
NVS
$263B
$228K ﹤0.01%
2,143
+44
+2% +$4.42K
IEMG icon
366
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
$222K ﹤0.01%
4,140
BNY
367
Bank of New York Mellon
BNY
$105B
$214K ﹤0.01%
3,574
-100
-3% -$5.79K
SOLV icon
368
Solventum
SOLV
$15.3B
$213K ﹤0.01%
+4,019
New +$244K
AFL icon
369
Aflac
AFL
$58.9B
$212K ﹤0.01%
2,375
FSLR icon
370
First Solar
FSLR
$21.7B
$211K ﹤0.01%
+935
New +$204K
NYT icon
371
New York Times
NYT
$11.6B
$210K ﹤0.01%
+4,102
New +$193K
IWF icon
372
iShares Russell 1000 Growth ETF
IWF
$123B
$210K ﹤0.01%
+2,300
New +$196K
LRCX icon
373
Lam Research
LRCX
$339B
$209K ﹤0.01%
+1,960
New +$188K
CNI icon
374
Canadian National Railway
CNI
$73.7B
$208K ﹤0.01%
1,765
-39,010
-96% -$4.88M
CME icon
375
CME Group
CME
$98.9B
$202K ﹤0.01%
1,030
+100
+11% +$20.7K

Similar funds

Boston Trust Walden's Q2 2024 Portfolio in Review

As of Q2 2024, Boston Trust Walden held 385 positions worth $13.5B, down 3.8% from $14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Boston Trust Walden's Q2 2024 filing shows 13 new, 113 increased, 185 reduced and 7 closed positions. Its largest new stake was Atkore: 172,729 shares worth $23.3M. The largest sale was Medpace, an estimated $43.2M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Boston Trust Walden's largest Q2 2024 buy was Atkore: 172,729 shares worth $23.3M.
  • Boston Trust Walden added most to NVIDIA in Q2 2024, an estimated $46.3M increase.
  • Boston Trust Walden's biggest Q2 2024 reduction was Medpace, cutting an estimated $43.2M.
  • Boston Trust Walden fully exited Callon Petroleum Company in Q2 2024, selling an estimated $35.4M.
  • Boston Trust Walden's ten largest holdings make up 20% of its $13.5B portfolio in Q2 2024.
  • Boston Trust Walden opened 13 new positions and closed 7 in Q2 2024.
  • Boston Trust Walden's portfolio value fell 3.8% quarter-over-quarter to $13.5B.

Based on Boston Trust Walden's 13F filing for Q2 2024, filed 19 Jul 2024.